Active Ingredient(s):Ertugliflozin + Sitagliptin Phosphate FDA Approved: * December 19, 2017 Pharm Company: *MERCK SHARP DOHME Category:Diabetes
Sitagliptin, sold under the brand name Januvia among others, is an anti-diabetic medication used to treat type 2 diabetes. In the United Kingdom it is listed as less preferred than metformin or a sulfonylurea. It is taken by mouth. It is also available in the fixed-dose combination medication sitagliptin/metformin (Janumet, Janumet XR).
Common side effects include headaches, swelling of the legs, and upper respiratory...
* May have multiple approval dates, manufacturers, or labelers.